1% atropine '5+3' regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 1% atropine '5+3' regimen, covering 2022-07-12 to 2022-07-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of 1% Atropine "5+3" Regimen in Children and Adolescents Controlling Myopia [Phase 4]